From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA
What they do
Acorai develops a handheld, non-invasive medical device that measures intracardiac pressure using machine learning and proprietary sensor technologies. Clinical teams use the device to assess congestion and adjust medication for heart failure patients in hospital settings.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Heart failure management
- Product type
- Device
- Stage
- Seed
- Headquarters
- Helsingborg, Sweden
- Region
- Europe
- Founded
- 2019
- Total funding
- $5M raised
Notable investors: Solas BioVentures, Carma Fund, Sweden Innovation, Supermoon Capital.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
Solving Healthcare's Hemodynamic Blind Spot: Quantitative Blood Volume Analysis and Inpatient Heart Failure Optimization
Dr. Dereck Mush, MD, MBA
Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA
The Agentic Clinical AI Regulatory Frontier: What ADVOCATE's $62.7M Contract Actually Unlocks
Dr. Dereck Mush, MD, MBA